Marks Benson Elizabeth, Pyrz Kaitlin, Wood Audria, Momaya Amit, Brabston Eugene, Evely Thomas, Casp Aaron
Department of Orthopaedics, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.
Augusta University/University of Georgia Medical Partnership, Athens, Georgia, U.S.A.
Arthrosc Tech. 2024 Jan 1;13(3):102877. doi: 10.1016/j.eats.2023.11.005. eCollection 2024 Mar.
Anterior cruciate ligament (ACL) rupture rates remain high; the incidence of isolated ACL ruptures is 68.6 per 100,000. This Technical Note introduces a technique for ACL reconstruction (ACLR) using a bone-tendon-bone (BTB) allograft augmented with BioBrace, a biocomposite scaffold. The BioBrace scaffold is sutured onto the BTB allograft to reinforce the ligament and accelerate healing. Graft preparation with BioBrace, ACLR, and graft passage is described. This technique aims to reduce re-rupture risk, enhance graft healing, and improve patient-reported outcomes. BioBrace offers advantages over other augmentation approaches and synthetic materials, providing improved remodeling, biologic integration, and increased mechanical strength. Feasibility and efficacy have been demonstrated in animal models and human applications. This technique presents a promising approach to enhance ACLR outcomes.
前交叉韧带(ACL)断裂率仍然很高;孤立性ACL断裂的发生率为每10万人68.6例。本技术说明介绍了一种使用BioBrace(一种生物复合支架)增强的骨-肌腱-骨(BTB)同种异体移植物进行ACL重建(ACLR)的技术。BioBrace支架缝合到BTB同种异体移植物上,以加强韧带并加速愈合。描述了使用BioBrace的移植物制备、ACLR和移植物植入过程。该技术旨在降低再次断裂风险,促进移植物愈合,并改善患者报告的结果。与其他增强方法和合成材料相比,BioBrace具有优势,可提供更好的重塑、生物整合和更高的机械强度。在动物模型和人体应用中已证明其可行性和有效性。该技术为提高ACLR结果提供了一种有前景的方法。